Graduated SPARK Norway projects

In addition to 19 active teams UiO:Life Science's innovation programme SPARK Norway has a portfolio of 23 alumni teams.

Development of a new product to relieve the symptoms of dry mouth

  • Project leader: Professor Marianne Hiorth, Department of Pharmacy, UiO
  • Team members: PhD student Julie Frig?rd, Professor Gro Smistad, Professor Janicke Liaaen Jensen and Professor Hilde Kanli Galtung

Targeting transcriptional addictions in glioblastomaImage may contain: Glasses, Forehead, Hair, Nose, Smile.

  • Project leader: Dr. Deo Pandey, Dept. of microbiology, Oslo University Hospital
  • Team members: Silje Lier, UiO

A solution to the kneecap fracture problem Image may contain: Nose, Cheek, Ear, Jaw, Neck.

  • Project leader: MD PhD Hendrik Fr?lich Stange Fuglesang, Orthopaedic department, Akershus University Hospital
  • Team members: MD Max J. Temmesfeld

A Novel Biomarker for Antibody Drug Conjugates Image may contain: Forehead, Nose, Cheek, Smile, Lip.

  • Project leader: Dr. Anette Weyergang, Institute for Cancer Research, Oslo University Hospital, Norwegian Radium Hospital
  • Team members: Dr. Kristian Berg and Dr. Olav Engebr?ten, The Radiumhospital Research Foundation

Image may contain: Face, Hair, Eyebrow, Forehead, Facial expression.MyFood – a decision support system to prevent and treat disease-related malnutrition

  • Project leader: PhD student Mari Mohn Paulsen, Department of Nutrition, Institute of Basic Medical Sciences, UiO
  • Team members: Professor Lene Frost Andersen, Dagfinn Bergsager and Gard O. S. Thomassen

Image may contain: Man, Face, Forehead, Head.Inhibition of aortic valve calcification

  • Project leader: Professor K?re-Olav Stensl?kken, Institute of Basic Medical Sciences, UiO
  • Team members: Professor emeritus Jarle Vaage and Dr. Arsenii Zabernyk

Image may contain: Face, Hair, Forehead, Eyebrow, Chin.A medical device for obesity treatment

  • Project leader: Christer T?nnesen, Department of Health Management and Health Economics (HELED), The Institute of Health and Society, UiO and Oslo University Hospital
  • Team members: Nj?l H?stm?lingen, Professor Michael Bretthauer, Associate Professor Magnus L?berg, Professor II Lars Aabakken, Marianne Lyngra and Yuichi Mori

Human antibodies for therapeutic, selective Notch targeting in rheumatoid arthritis

  • Project leader: Guttorm Haraldsen, center leader, UiO
  • Team members: Anita Kavlie, Stig Krüger and Katarzyna Marciniak

    Healthy soils for a healthy life 

    A novel vaccine technology platform

    • Project leader: Malin Bern, postdoc, Oslo University Hospital (OUS)
    • Team members: Jan Terje Andersen (UiO) and Inger Sandlie (UiO)

    High-Performance Cyclotron Target for Gallium-68 

    • Project leader: Bent W. Schoultz, Associate Professor, Norwegian Nuclear Research Center, Dep. of physics, UiO
    • Team members: Andreas G?rgen and Sunniva Siem (UiO) as well as Elin Melby and Bjarne Tvete (Inven2)

    A biologic therapeutic for pulmonary fibrosis 

    • Project leader: Ole J?rgen Kaasb?ll, researcher, Inst. clin. med., UiO
    • Team member: H?vard Attramadal, Inst. clin. med. (UiO)

    Novel treatment for heart failure                                          

    IVF FitTM: Optimising in vitro fertilisation hormone dosage 

    A novel strategy to tailor the pharmacokinetics of IgA antibodies          

    Tankyrase inhibition in cancer immune therapy                                     

    • Project leader: Jo Waaler, Faculty of Medicine, UiO
    • Team member: Stefan Krauss, (UiO and OUS)

     

    Novel therapy for currently untreatable hypertension

    Restoration of a functional urinary bladder using cutting-edge technology

    Novel therapy for ischemic reperfusion injury                                        

    RACeR: Improvement of A Genetic Tool that Enhances Homology Dependent Gene Repair

    Petomics: a commercial Norwegian microbiome service for performance animals and pets

    • Project leader: P?l Trosvik, UiO
    • Team member: Eric Jacques de Muinck

    Influenza vaccine that can be rapidly produced to counter an emerging pandemic threat

    Targeted pharmacological treatment of ventricular arrhythmias

    Published Aug. 2, 2022 10:43 AM - Last modified Mar. 6, 2024 10:51 AM